Comparable Glucose Control with Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System During Exercise,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comparable Glucose Control with Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System During Exercise
Diabetes Technology & Therapeutics ( IF 5.4 ) Pub Date : 2022-01-31 , DOI: 10.1089/dia.2021.0221
Dale Morrison ₁ , Dessi P Zaharieva ₂ , Melissa H Lee _{1,

3} , Barbora Paldus _{1,

3} , Sara Vogrin ₁ , Benyamin Grosman ₄ , Anirban Roy ₄ , Natalie Kurtz ₄ , David Norman O'Neal _{1,

3}

Affiliation

Background: This study compared glucose control with fast-acting insulin aspart (FiAsp) versus insulin aspart following moderate-intensity exercise (MIE) and high-intensity exercise (HIE) using a second-generation closed-loop (CL) system in people with type 1 diabetes.

中文翻译：